FDA.reportPublic FDA data

{112 (treprostinil 0.016 MG Inhalation Powder) / 84 (treprostinil 0.032 MG Inhalation Powder) } Pack

RxCUI
2602767
RxNorm name
{112 (treprostinil 0.016 MG Inhalation Powder) / 84 (treprostinil 0.032 MG Inhalation Powder) } Pack
Display name
{112 (treprostinil 0.016 MG Inhalation Powder) / 84 (treprostinil 0.032 MG Inhalation Powder) } Pack
Full name
{112 (treprostinil 0.016 MG Inhalation Powder) / 84 (treprostinil 0.032 MG Inhalation Powder) } Pack
Term type
GPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ddc3d400-bcb3-4b09-aae2-0768b10a5b0f{112 (treprostinil 0.016 MG Inhalation Powder) / 84 (treprostinil 0.032 MG Inhalation Powder) } PackGPCK14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0ftreprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG)PSN14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0ftreprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG)SY14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120